Your shopping cart is currently empty

CDK7-IN-27 (Compound 37) is a selective inhibitor of cyclin-dependent kinase 7 (CDK7), with a Ki value of 3 nM. It effectively causes cell cycle arrest at the G0/G1 phase.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | CDK7-IN-27 (Compound 37) is a selective inhibitor of cyclin-dependent kinase 7 (CDK7), with a Ki value of 3 nM. It effectively causes cell cycle arrest at the G0/G1 phase. |
| Targets&IC50 | CDK7:3 nM, CDK2:19.4 nM |
| In vitro | CDK7-IN-27 effectively inhibits the proliferation of MDA-MB-453 cells with an EC50 of 1.49 μM when used in concentrations ranging from 0.04 to 10 μM over the course of 5 days. At a concentration of 1 μM over 24 hours, CDK7-IN-27 demonstrates good metabolic stability in both mouse and human liver microsomes, with half-life periods of 38.5 minutes and 34.1 minutes, respectively. Additionally, CDK7-IN-27 (0-1 μM, 24 h) arrests the cell cycle in the G0/G1 phase by inhibiting the phosphorylation of retinoblastoma protein through CDK7 inhibition. |
| Formula | C26H37N7O2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.